Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
05/28/2013 | PORTOLA PHARMACEUTICALS INC | PTLA | Conversion | Series D Preferred Stock | 106.1k | $0.00 | $0 | Prospect Venture Partners II, L.P. | 05/28/2013 |
05/28/2013 | PORTOLA PHARMACEUTICALS INC | PTLA | Conversion | Series D Preferred Stock | 1.6k | $0.00 | $0 | Prospect Associates II, L.P. | 05/28/2013 |
05/28/2013 | PORTOLA PHARMACEUTICALS INC | PTLA | Conversion | Series C Preferred Stock | 372.7k | $0.00 | $0 | Prospect Venture Partners II, L.P. | 05/28/2013 |
05/28/2013 | PORTOLA PHARMACEUTICALS INC | PTLA | Conversion | Series C Preferred Stock | 5.7k | $0.00 | $0 | Prospect Associates II, L.P. | 05/28/2013 |
05/28/2013 | PORTOLA PHARMACEUTICALS INC | PTLA | Conversion | Series B Preferred Stock | 353.8k | $0.00 | $0 | Prospect Venture Partners II, L.P. | 05/28/2013 |
05/28/2013 | PORTOLA PHARMACEUTICALS INC | PTLA | Conversion | Series B Preferred Stock | 5.4k | $0.00 | $0 | Prospect Associates II, L.P. | 05/28/2013 |
05/28/2013 | PORTOLA PHARMACEUTICALS INC | PTLA | Conversion | Series A Preferred Stock | 956k | $0.00 | $0 | Prospect Venture Partners II, L.P. | 05/28/2013 |
05/28/2013 | PORTOLA PHARMACEUTICALS INC | PTLA | Conversion | Series A Preferred Stock | 14.6k | $0.00 | $0 | Prospect Associates II, L.P. | 05/28/2013 |
05/28/2013 | PORTOLA PHARMACEUTICALS INC | PTLA | Conversion | Common Stock | 1.8M | $0.00 | $0 | Prospect Venture Partners II, L.P. | 05/28/2013 |
05/28/2013 | PORTOLA PHARMACEUTICALS INC | PTLA | Conversion | Common Stock | 27.2k | $0.00 | $0 | Prospect Associates II, L.P. | 05/28/2013 |
05/25/2012 | HANSEN MEDICAL INC | HNSN | Grant | Stock Option (Right to Buy) | 10k | $2.49 | $24.9k | | 05/25/2012 |
06/15/2011 | HANSEN MEDICAL INC | HNSN | Grant | Stock Option (Right to Buy) | 10k | $2.67 | $26.7k | | 06/15/2011 |
12/02/2010 | AVEO PHARMACEUTICALS, INC. | AVEO | Sale | Common Stock | 4.8k | $14.93 | $72.2k | By Prospect Associates II, L.P. | 12/02/2010 |
12/02/2010 | AVEO PHARMACEUTICALS, INC. | AVEO | Sale | Common Stock | 317.6k | $14.93 | $4.7M | By Prospect Venture Partners II, L.P. | 12/02/2010 |
06/17/2010 | AVEO PHARMACEUTICALS, INC. | AVEO | Grant | Stock Option (right to buy) | 12.5k | $7.44 | $93k | | 06/17/2010 |
03/17/2010 | AVEO PHARMACEUTICALS, INC. | AVEO | Conversion | Common Stock | 10.9k | $0.00 | $0 | By Prospect Associates II, L.P. | 03/17/2010 |
03/17/2010 | AVEO PHARMACEUTICALS, INC. | AVEO | Conversion | Common Stock | 10.8k | $0.00 | $0 | By Prospect Associates II, L.P. | 03/17/2010 |
03/17/2010 | AVEO PHARMACEUTICALS, INC. | AVEO | Conversion | Common Stock | 2.5k | $0.00 | $0 | By Prospect Associates II, L.P. | 03/17/2010 |
03/17/2010 | AVEO PHARMACEUTICALS, INC. | AVEO | Conversion | Common Stock | 715k | $0.00 | $0 | By Prospect Venture Partners II, L.P. | 03/17/2010 |
03/17/2010 | AVEO PHARMACEUTICALS, INC. | AVEO | Conversion | Common Stock | 709.7k | $0.00 | $0 | By Prospect Venture Partners II, L.P. | 03/17/2010 |
03/17/2010 | AVEO PHARMACEUTICALS, INC. | AVEO | Conversion | Common Stock | 163k | $0.00 | $0 | By Prospect Venture Partners II, L.P. | 03/17/2010 |
03/17/2010 | AVEO PHARMACEUTICALS, INC. | AVEO | Conversion | Series A Convertible Preferred Stock | 43.6k | $0.00 | $0 | By Prospect Associates II, L.P. | 03/17/2010 |
03/17/2010 | AVEO PHARMACEUTICALS, INC. | AVEO | Conversion | Series B Convertible Preferred Stock | 43.2k | $0.00 | $0 | By Prospect Associates II, L.P. | 03/17/2010 |
03/17/2010 | AVEO PHARMACEUTICALS, INC. | AVEO | Conversion | Series D Convertible Preferred Stock | 9.9k | $0.00 | $0 | By Prospect Associates II, L.P. | 03/17/2010 |
03/17/2010 | AVEO PHARMACEUTICALS, INC. | AVEO | Conversion | Series A Convertible Preferred Stock | 2.9M | $0.00 | $0 | By Prospect Venture Partners II, L.P. | 03/17/2010 |
03/17/2010 | AVEO PHARMACEUTICALS, INC. | AVEO | Conversion | Series B Convertible Preferred Stock | 2.8M | $0.00 | $0 | By Prospect Venture Partners II, L.P. | 03/17/2010 |
03/17/2010 | AVEO PHARMACEUTICALS, INC. | AVEO | Conversion | Series D Convertible Preferred Stock | 651.9k | $0.00 | $0 | By Prospect Venture Partners II, L.P. | 03/17/2010 |